2025 annual financial data
Voyager Therapeutics 2025 Net income growth
Direct answer
Net income growth was -84.18%.
Operating income was -131,844,000 USD and net income was -119,721,000 USD.
Operating cash flow was -132,467,000 USD.
Get free Voyager Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 40,374,000 USD
- Operating income
- -131,844,000 USD
- Net income
- -119,721,000 USD
- Operating cash flow
- -132,467,000 USD